Teres Major Muscle and Subacromial Impingement Syndrome
- Conditions
- Subacromial Impingement SyndromeTrigger Points in Teres Major Muscle
- Interventions
- Device: Diacutaneous FibrolysisOther: Trigger Point Pressure ReleaseOther: Protocolized physiotherapy
- Registration Number
- NCT02374125
- Lead Sponsor
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- Brief Summary
There is not a clear understanding of the origin of symptoms perceived by patients with impingement of the soft tissue structures of the subacromial space. Tendinopathy, tendon rupture or other pathologies, are present in asymptomatic subjects and subjects with symptoms and structural integrity can also be found.
Patients diagnosed with subacromial impingement syndrome frequently have myofascial trigger points in the teres major muscle. Travell and Simons reported that the symptoms caused by trigger points in this muscle are similar to those experienced by patients diagnosed with impingement syndrome, but a literature search provides few results regarding relationship between subacromial impingement syndrome and presence of myofascial trigger points in the teres major muscle.
This study aims to provide evidence of the results that can be obtained with a specific approach of teres mayor muscle by two manual techniques, Trigger Point Pressure Release and Diacutaneous Fibrolysis, in subjects with subacromial impingement syndrome, a condition that still representing both a diagnostic and therapeutic challenge. Secondary objective is to compare the outcomes between both techniques to select for each patient the most appropriate to their needs and characteristics.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 96
- Age 18 years and over
- Clinical diagnosis of Subacromial Impingement Syndrome.
- Detectable trigger points in teres major muscle.
- Sign informed consent form.
- Diacutaneous Fibrolysis contraindications
- Previous shoulder surgery (<1year)
- Language barriers or cognitive issues that limit their ability to provide informed consent and participate in research.
- Patients with a pending litigation or court claim.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fibrolysis Group Diacutaneous Fibrolysis Actual Diacutaneous Fibrolysis and protocolized physiotherapy Fibrolysis Group Protocolized physiotherapy Actual Diacutaneous Fibrolysis and protocolized physiotherapy Pressure Group Protocolized physiotherapy Trigger Point Pressure Release and protocolized physiotherapy Pressure Group Trigger Point Pressure Release Trigger Point Pressure Release and protocolized physiotherapy Control Group Protocolized physiotherapy Protocolized physiotherapy
- Primary Outcome Measures
Name Time Method Change in Pain intensity (Using a VAS) Change from baseline to 3 weeks. Using a VAS
Change in Functional capacity (Abbreviated Constant-Murley score) Change from baseline to 3 weeks. Abbreviated Constant-Murley score
- Secondary Outcome Measures
Name Time Method Change in Active Range of Motion Change from baseline to 3 weeks. Flexion, extension, abduction, external rotation and internal rotation
Patient perception of change (Global Rating of Change scale) 3 weeks after recruitment Global Rating of Change scale
Trial Locations
- Locations (1)
Catalan Health Institut. Sant Ildefons Rehabilitation Service
🇪🇸Cornellà de Llobregat, Barcelona, Spain